Citigroup Inc Dice Therapeutics, Inc. Transaction History

Citigroup Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$25.86 - $46.71 $299,898 - $541,695	11,597 Added 188.42%	17,752 $824,000
Q1 2023 May 11, 2023	SELL	$26.05 - $32.31 $6,668 - $8,271	-256 Reduced 3.99%	6,155 $176,000
Q4 2022 Feb 09, 2023	BUY	$19.77 - $42.23 $24,870 - $53,125	1,258 Added 24.41%	6,411 $200,000
Q3 2022 Nov 10, 2022	SELL	$14.97 - $22.65 $26,931 - $40,747	-1,799 Reduced 25.88%	5,153 $105,000
Q2 2022 Aug 10, 2022	SELL	$13.19 - $22.1 $39,002 - $65,349	-2,957 Reduced 29.84%	6,952 $108,000
Q1 2022 May 12, 2022	SELL	$14.54 - $25.02 $58,494 - $100,655	-4,023 Reduced 28.88%	9,909 $190,000
Q4 2021 Feb 10, 2022	BUY	$22.41 - $37.54 $282,948 - $473,980	12,626 Added 966.77%	13,932 $353,000
Q3 2021 Nov 10, 2021	BUY	$31.92 - $37.0 $41,687 - $48,322	1,306 New	1,306 $43,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.